James C Lynch Selected Research

James C Lynch Research Topics

Disease

9	Neoplasms (Cancer) 01/2015 - 06/2002
4	Rhabdomyosarcoma 12/2011 - 06/2002
4	Fatigue 12/2009 - 11/2002
4	Breast Neoplasms (Breast Cancer) 12/2009 - 11/2002
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2008 - 04/2002
3	Sepsis (Septicemia) 01/2020 - 07/2017
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2005 - 04/2002
2	Hypotension (Low Blood Pressure) 01/2022 - 01/2020
2	Septic Shock (Toxic Shock Syndrome) 01/2020 - 07/2017
2	Disease Progression 09/2007 - 03/2006
1	Critical Illness (Critically Ill) 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2017
1	Adenocarcinoma 01/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2015
1	Neutropenia 12/2014
1	Infections 12/2014
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 12/2014
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2008
1	Lymphoma (Lymphomas) 01/2008
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 09/2007
1	Disease Resistance 09/2007
1	Alveolar Bone Loss 09/2007
1	Bronchiolitis Obliterans Syndrome 04/2005
1	Chromosome Aberrations (Chromosome Abnormalities) 02/2005
1	Residual Neoplasm 05/2002

Drug/Important Bio-Agent (IBA)

3	6- phenyl- 7(6H)- isoselenazolo(4,3- d)pyrimidoneIBA 12/2009 - 05/2003
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 01/2020
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2011 - 06/2002
2	Complementary DNA (cDNA)IBA 02/2005 - 04/2002
2	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2003 - 11/2002
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Oncogene Proteins (Oncogene Protein)IBA 01/2017
1	SurvivinIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Trypan Blue FDA Link 01/2015
1	turmeric extractIBA 01/2015
1	CurcuminIBA 01/2015
1	resazurinIBA 01/2015
1	Vinblastine (Vinblastine Sulfate)FDA Link 12/2014
1	RNA (Ribonucleic Acid)IBA 12/2011
1	Monoclonal AntibodiesIBA 01/2008
1	Doxycycline (Periostat)FDA LinkGeneric 09/2007
1	Formaldehyde (Formol)FDA Link 05/2006
1	ParaffinIBA 05/2006
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 03/2006
1	OligonucleotidesIBA 03/2006
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2006
1	Insulin-Like PeptidesIBA 03/2006
1	Cyclin D2IBA 10/2005
1	Protein Kinase C betaIBA 10/2005
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 02/2005
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2005
1	Melphalan (Alkeran)FDA LinkGeneric 01/2005
1	Etoposide (VP 16)FDA LinkGeneric 01/2005
1	Carmustine (FIVB)FDA Link 01/2005
1	tositumomab I-131 (Bexxar)FDA Link 01/2005
1	Cyclin D1IBA 02/2003
1	Messenger RNA (mRNA)IBA 02/2003
1	DNA (Deoxyribonucleic Acid)IBA 06/2002
1	Vincristine (Oncovin)FDA LinkGeneric 04/2002
1	Mitoxantrone (Novantrone)FDA LinkGeneric 04/2002
1	Prednisone (Sone)FDA LinkGeneric 04/2002
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2002

Therapy/Procedure

8	Therapeutics 01/2022 - 02/2003
6	Drug Therapy (Chemotherapy) 06/2009 - 05/2002
3	Stem Cell Transplantation 01/2008 - 01/2005
2	Resuscitation 07/2019 - 07/2017
2	Adjuvant Chemotherapy 12/2009 - 06/2009
2	Transplantation 01/2008 - 04/2005
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 04/2005 - 08/2003
1	Drug Tapering 12/2014
1	Relaxation Therapy (Relaxation Technique) 06/2009
1	Time-to-Treatment 02/2005
1	Autologous Transplantation 05/2002
1	Hematopoietic Stem Cell Transplantation 05/2002